Identification of a Novel Pathogenic Rearrangement Variant of the APC Gene Associated with a Variable Spectrum of Familial Cancer
Autor: | Diana Cristina Pérez-Ibave, Victor Trevino, Carlos Horacio Burciaga-Flores, Hazyadee Frecia Rodríguez-Gutiérrez, Antonio Alí Pérez-Maya, Genaro A. Ramirez-Correa, Moises Gonzalez-Escamilla, María Lourdes Garza-Rodríguez, Oscar Vidal-Gutiérrez, Miguel Angel Elizondo-Riojas |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Proband medicine.medical_specialty Adenomatous polyposis coli Genetic counseling Clinical Biochemistry familial adenomatous polyposis (FAP) rearrangement Case Report Germline Familial adenomatous polyposis 03 medical and health sciences symbols.namesake 0302 clinical medicine adenomatous polyposis coli (APC) medicine Sanger sequencing Genetics lcsh:R5-920 biology pathogenic germline variant Cancer medicine.disease 030104 developmental biology 030220 oncology & carcinogenesis symbols biology.protein Medical genetics lcsh:Medicine (General) |
Zdroj: | Diagnostics Diagnostics, Vol 11, Iss 411, p 411 (2021) |
ISSN: | 2075-4418 |
Popis: | Familial adenomatous polyposis (FAP) is an autosomal-dominant condition characterized by the presence of multiple colorectal adenomas, caused by germline variants in the adenomatous polyposis coli (APC) gene. More than 300 germline variants have been characterized. The detection of novel variants is important to understand the mechanisms of pathophysiology. We identified a novel pathogenic germline variant using next-generation sequencing (NGS) in a proband patient. The variant is a complex rearrangement (c.422+1123_532-577 del ins 423-1933_423-1687 inv) that generates a complete deletion of exon 5 of the APC gene. To study the variant in other family members, we designed an endpoint PCR method followed by Sanger sequencing. The variant was identified in the proband patient’s mother, one daughter, her brother, two cousins, a niece, and a second nephew. In patients where the variant was identified, we found atypical clinical symptoms, including mandibular, ovarian, breast, pancreatic, and gastric cancer. Genetic counseling and cancer prevention strategies were provided for the family. According to the American College of Medical Genetics (ACMG) guidelines, this novel variant is considered a PVS1 variant (very strong evidence of pathogenicity), and it can be useful in association with clinical data for early surveillance and suitable treatment. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |